BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 6
• 7
• 8
• 9
• 10
• 13
• 14
• 15
• 16
• 17
• 18
• 20
• 21
• 22
• 23
• 24
• 27
• 28
• 29
• 30
• 31

• Oxford Gene Technology Ltd.’s Array Technology To Boost Prokaryote Genomics Research

  October 2, 2008

   · 

  1 min read
• Business

  Nextrials, Inc. Positions Strategic Sales Force Across The U.S. For Improved Customer Access And Service

  October 2, 2008

   · 

  1 min read
• Business

  Adaltis Inc. Announces Changes To Board Of Directors

  October 2, 2008

   · 

  1 min read
• Business

  Chembio Diagnostics, Inc. And Oswaldo Cruz Foundation Sign Agreement For DPP(R) Oral Fluid - Whole Blood HIV Test

  October 2, 2008

   · 

  1 min read
• BioMidwest

  Medtronic, Inc. Warns Doctors Of Drug Pump Problems

  October 2, 2008

   · 

  1 min read
• Business

  Arana Therapeutics Completes A Series Of Humanised And Improved Antibodies For Vegenics Limited’ Cancer Treatment Program

  October 2, 2008

   · 

  3 min read
• Business

  IBA Health (ASX:IBA) iSoft Wins A$7.6 Million LORENZO Deal At New Macquarie University Private Hospital

  October 2, 2008

   · 

  5 min read
• Pharm Country

  Q Pharma, Inc. Launches iValidate 2.0

  October 2, 2008

   · 

  1 min read
• Policy

  Cell Therapeutics, Inc. Submits Supplemental Biologics License Application for Zevalin Use in First-Line Consolidation Therapy Approval would make Zevalin only Radioimmunotherapy in U.S. to be Indicated for Use in First-Line Therapy

  October 2, 2008

   · 

  6 min read
• Deals

  Milestone Scientific Acquires Additional Patent Rights for Painless Injections and Resolves Related Litigations

  October 2, 2008

   · 

  3 min read